Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Safety Assessment of a Quadrivalent Subunit Influenza Vaccine Following Post-Marketing in China: An Open-Label, Single-Arm Clinical Trial

NCT07710586 is registered in ClinicalTrials.gov with Ab&B Bio-tech Co., Ltd.JS as lead sponsor.

NCT NCT07710586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07710586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Safety Assessment of a Quadrivalent Subunit Influenza Vaccine Following Post-Marketing in China: An Open-Label, Single-Arm Clinical Trial
Lead sponsor
Ab&B Bio-tech Co., Ltd.JS
Phase
Phase 4
Overall status
Completed
Start date
November 15, 2024
Completion date
May 29, 2025
Enrollment
3,105 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza vaccine